Concepedia

Efficacy of satralizumab (SA237) in subgroups of patients in SAkuraSky: a Phase III double-blind, placebo-controlled, add-on study in patients with neuromyelitis optica spectrum disorder (NMOSD) (S43.008)

Takashi Yamamura, Ingo Kleiter, Kazuo Fujihara, Jacqueline Palace, Benjamin Greenberg, Beata Zakrzewska‐Pniewska, Francesco Patti, Ching Piao Tsai, Albert Saiz, Masayuki Haramura,

Neurology · 2019 · 13 citations · 0 references

DOI

Concepts

Abstract

To evaluate the efficacy of satralizumab (SA237) in subgroups of the SAkuraSky study (NCT02028884).